No reason to go dark if going private or bankruptcy. Trying to extend life of co. To see if sales ever come in. As far as 27 shareholders that is misleading. Each firm holds shares in street name so unless you hold physical cert. Example, fidelity would be counted as one shareholder regardless of how many clients hold the stock. No pump just facts. Call Steve or Paul and they will call you back.(781)-434-0231 781-434-0210
Yes product fees paid to BG, based on ABT sales. They are actually like royalty payments. They said nothing about that March 1st payment, no guidance from them.
Maybe it's just me but I don't recall any mention of ABT "sales". They only made mention of "Product fees". The word "sales" seems conveniently absent as it relates to Abbot. Again, that was a long and tedious 10k - eyes started to glaze over after the 3rd line - and I'm sure going senile here as well. I just find it puzzling we have too peel 50 million layers of legalize talk to know actual sales for Q1 and sales guidance going forward.
I doubt about BO in near future...they need a year or so to predict future sales...they definitely wan't to hide numbers...most of Flagship Venture companies are private so this is the cheapest way for BGMD...i hope they will be prosecuted one day...everything was made on purpose they can get 1 more million from Emery Asset Management when they did dilution and could have enough cash till next year....and as a result enough resources to proceed with all filling requirements...
No buyout. They orchestrated all this to go private.
List the events over the last year and connect the dots.
They kept the company liquid just long enough to use it as an ATM for their salaries. Ask yourself who has purchase over 1 million shares in the least 3 days?
They #$%$ retail shareholders. Wait and see.
BO would be calculated as revenue to be earned by BG over the remaining years of patent life. Basically patent expires in 10 yrs. so 10 yrs times yearly royalty revenue expected. This is "IF" there is an actual BO.
Yes. I was expecting them to give guidance for Q1 as they were supposed to receive the first real payment from ABT on March 1St ( 1st payment after ABT officially started marketing test, also on ABT Homepage). That payment was to be for ABT sales during Q4. They just went dark on us, as sales are probably starting to ramp up. We will never know with these guys. It may be to hide any possible valuation of the company by any outsiders like us shareholders, in case of a BO. I'm not expecting more than 2$ BO, but would be even happy with 75 cents at this point.
I remember the WEBINAR: Galectin-3 A Step Towards a Clearer Pathway in Heart Failure Management on September 22 2015. Dr.Peter McCullough told at the end of session that test will be available in all major centres in coming week (weeks)...correct me if i wrong...what actually tells us?...it tells that Abbott did not starts actual sales of test till end of September, early October...if you check attendees you can find large number sales representatives and ambassadors of Abbott who actually asked obvious questions about Galectin-3..which means they were not so familiar with product..so BGMD told us that they receive royalties payment from Abbott within 60 days after each quarter...No surprise that they received almost nothing within 60 days after September 30th (end of November) as sales did not start yet and as result we don't see actual revenue increase in Q4....Abbott actual sales from October to December, BGMD should received royalties for Q4 from ABT in 60 days (end February) and we would see revenues increase in Q1 2016..but suddenly they decide to become non reporting company...i believe this is on purpose just to hide revenues and mislead investors...
Yes. As I said in a recent post this week selling now makes little difference in my overall
loss so i am not selling. Waiting. The 27 stockholders on the 15th are now probably
much less after yesterdays sell off and purchase . If they tender an offer to remaining shareholders then it will be at least what it is listed on the market. In any case, if this goes as I suspect I will enthusiastically join a lawsuit. Pursuance of charges against the
company and its officers for lack of fiduciary duty will be the minimum. There is also
evidence of the company communicating misleading information about the
delisting dates and process. Perhaps the DOJ and the AG office will be interested
in this scam. Hall has a previous history of being involved with companies that go
bankrupt. Management thinks they are untouchable. Remember two immediate
dilutions right after the reverse and they didnt even obtain the necessary equity.
Like they can't add? Looks very bad
. Think of how easy it would be for an investigation
to see who bought all the shares on Monday and if they are tied to management in any
way. Could be this is why Noubar stepped down as a director recently to distance any
purchase of remaining shares under these conditions. Management must think
everyone is stupid
Someone is buying after they drove out retail to go private just at the time of expected revenue
from Abbott.. They deliberately drove the stock into the ground over the last year.
Each action they took is well known to have a negative effect on a stock.
Drive it to nothing, flush out as many retail holders with a final
announcement of deregistration and pick up outstanding shares. Look at the volume the last three days.
Management should be horsewhipped.
The biggest indictment is how all of this just happened as the Abbot deal went into effect and commercialization just started. Just when milestones were to be met or not? We will never know. It does stink to high heaven. This company managed to squeeze 166 million since it's inception from investors and the day it's product is about to go national and global it plays dead. How convenient. Sales might go dud but if the galectin test kit at it's height did over 2-4 million in sales - no reason the automated test won't do as well - and better going forward. imo
Man that thing is long and deep. But this was the most interesting part I got:
As of March 15, 2016, there were approximately 27 stockholders of record of the 11,319,475 outstanding shares of our common stock.
Proud to be part of a select group but that means there are people with a lot more to lose than me. Plus Flagship still owns over 11%.
Now the 10-K was nothing but negative but who the heck is buying all the shares being sold if there are only 27 of us?
Or, someone on behalf of the company is buying
all the available shares to go private and the
company will tender an offer to the remaining retail
shareholders for peanuts. Either way this stinks to
As I stated in another thread I sense now that they are going dark is that they are taking this to bankruptcy, scoop up the
license and go private. They #$%$ the retail shareholders
and milked the company for salary. How difficult was
it to raise and know enough equity to stay listed? (easier to
fail and decimate the stock).
How difficult was it to submit the wider indication
with the necessary information the FDA needed. This was
already done in Europe (much easier to fail at this and
withdraw the application and decimate the stock).
So going through the motions they could pretend they were
trying but in realty they were deliberately clearing a course
for bankruptcy to be free of the public. Then go private
and just sit back and collect from Abbott and the automated
test. Just watch. Hall has a history with bankruptcy. Now there
is a clear pattern.